Science Explorer Back to mapMap
Institution · Jinyintan Hospital

Most cited papers from Jinyintan Hospital

What are the most cited papers from Jinyintan Hospital?

The most cited paper from Jinyintan Hospital is "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study" (Fei Zhou, Ting Yu, Ronghui Du et al., 2020), with 29,236 citations. Next come "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study" (22,766) and "Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China" (8,770).

Showing 50 of 57 papers. Every paper with more than 123 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet Open access Mar 2020 29,236
2 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Nanshan Chen, Min Zhou, Xuan Dong et al. · The Lancet Open access 30 Jan 2020 22,766
3 Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China Chaomin Wu et al. · JAMA Internal Medicine Open access 13 Mar 2020 8,770
4 Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Heshui Shi, Xiaoyu Han, Nanchuan Jiang et al. · The Lancet Infectious Diseases Open access 24 Feb 2020 3,853
5 Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis Wei-Jie Guan et al. · European Respiratory Journal Open access 26 Mar 2020 3,777
6 Effectiveness of convalescent plasma therapy in severe COVID-19 patients Kai Duan et al. · Proceedings of the National Academy of Sciences Open access 6 Apr 2020 2,029
7 Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 Wenhua Liang, Hengrui Liang, Limin Ou et al. · JAMA Internal Medicine Open access 12 May 2020 1,530
8 Clinical characteristics of 2019 novel coronavirus infection in China Wei‐jie Guan et al. · medRxiv PreprintOpen access 9 Feb 2020 1,486
9 Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study Li-li Ren et al. · Chinese Medical Journal Open access 6 Feb 2020 1,405
10 SARS-CoV-2 and viral sepsis: observations and hypotheses Hui Li, Liang Liu, Dingyu Zhang et al. · The Lancet Open access 17 Apr 2020 1,256
11 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Lixue Huang et al. · The Lancet Open access Aug 2021 1,149
12 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chaolin Huang et al. · The Lancet Open access Jun 2023 905
13 COVID-19 with Different Severities: A Multicenter Study of Clinical Features Yun Feng et al. · American Journal of Respiratory and Critical Care Medicine Open access 10 Apr 2020 897
14 Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin Peng Zhou et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 23 Jan 2020 730
15 Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Ruchong Chen et al. · CHEST Journal Open access 15 Apr 2020 694
16 Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia Xiaoyu Han, Yanqing Fan, Osamah Alwalid et al. · Radiology Open access 26 Jan 2021 663
17 Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility Jiao Zhao, Yan Yang, Han-Ping Huang et al. · Clinical Infectious Diseases Open access 3 Aug 2020 578
18 Thrombocytopenia and its association with mortality in patients with COVID‐19 Xiaobo Yang, Qingyu Yang, Yaxin Wang et al. · Journal of Thrombosis and Haemostasis Open access 17 Apr 2020 575
19 Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study Jianbo Tian et al. · The Lancet Oncology Open access 29 May 2020 554
20 The ORF3a protein of SARS-CoV-2 induces apoptosis in cells Yujie Ren, Ting Shu, Di Wu et al. · Cellular and Molecular Immunology Open access 18 Jun 2020 518
21 Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes Ying Xiong, Dong Sun, Yao Liu et al. · Investigative Radiology Open access 5 Mar 2020 498
22 Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Ke Hu, Wei‐jie Guan, Ying Bi et al. · Phytomedicine Open access 16 May 2020 469
23 Relationship between the ABO Blood Group and the COVID-19 Susceptibility Jiao Zhao, Yan Yang, Han-Ping Huang et al. · medRxiv PreprintOpen access 16 Mar 2020 455
24 Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients Chaofu Wang et al. · EBioMedicine Open access 20 Jun 2020 435
25 High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 Wei Cao, Xiaosheng Liu, Tao Bai et al. · Open Forum Infectious Diseases Open access Mar 2020 419
26 Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Ruchong Chen et al. · Journal of Allergy and Clinical Immunology Open access 11 May 2020 417
27 Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a Shuhan Lu, Xiaohan Tong, Yang Han et al. · Nature Biomedical Engineering Open access 21 Mar 2022 397
28 Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19 Ting Shu et al. · Immunity Open access 20 Oct 2020 391
29 Plasma metabolomic and lipidomic alterations associated with COVID-19 Di Wu et al. · National Science Review Open access 25 Apr 2020 373
30 Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China Wenhua Liang et al. · European Respiratory Journal Open access 8 Apr 2020 340
31 Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study Chun Shui Pan, Lü Chen, Cong Lü et al. · American Journal of Respiratory and Critical Care Medicine Open access 23 Mar 2020 338
32 Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China Jiqian Xu et al. · Critical Care Open access 6 Jul 2020 254
33 Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold-Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19) Jie Xiang, Mingzhe Yan, Hongze Li et al. · medRxiv PreprintOpen access Mar 2020 248
34 SARS-CoV-2 cell tropism and multiorgan infection Jia Liu, Yufeng Li, Qian Liu et al. · Cell Discovery Open access 23 Mar 2021 245
35 COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study Songjiang Huang, Jianwen Wang, Fen Liu et al. · Hypertension Research Open access Jun 2020 232
36 Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus Yao Li, Haifang Wang, Xin Li et al. · Clinical Science Open access 14 Mar 2019 227
37 SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2 Jingfang Mu, Yaohui Fang, Qi Yang et al. · Cell Discovery Open access 15 Sep 2020 223
38 Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study Yu Lai Yuan et al. · Critical Care Open access 14 May 2020 220
39 Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease Weijun Wang, Jinfang Zhao, Wenfang Gui et al. · British Journal of Pharmacology Open access 15 Nov 2017 204
40 SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts Ting Shu, Muhan Huang, Di Wu et al. · Virologica Sinica Open access Jun 2020 196
41 Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study Yinggang Zhu, Mengmeng Shi, Antoine Monsel et al. · Stem Cell Research & Therapy Open access 26 May 2022 194
42 Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome Jiao Liu, Sheng Zhang, Xuan Dong et al. · Journal of Clinical Investigation Open access 2 Nov 2020 188
43 Intensive care during the coronavirus epidemic Haibo Qiu, Zhaohui Tong, Penglin Ma et al. · Intensive Care Medicine Open access 20 Feb 2020 175
44 Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients Xixiang Ma, Chuhuai Guan, Rong Chen et al. · Cellular and Molecular Immunology Open access 14 Dec 2020 168
45 Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients Zhi-Sheng Xu, Ting Shu, Liang Kang et al. · Signal Transduction and Targeted Therapy Open access 19 Jun 2020 156
46 Autopsy of COVID-19 patients in China Xiu‐Wu Bian et al. · National Science Review Open access 5 Jun 2020 155
47 A cohort autopsy study defines COVID-19 systemic pathogenesis Xiao-Hong Yao et al. · Cell Research Open access 16 Jun 2021 153
48 SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells Jingfang Mu, Jiuyue Xu, Leike Zhang et al. · Science China Life Sciences Open access 10 Apr 2020 152
49 Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions Zhiruo Zhang, Shelan Liu, Mi Xiang et al. · Frontiers of Medicine Open access 23 Mar 2020 151
50 Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study Jiao Liu, Sheng Zhang, Zhixiong Wu et al. · Annals of Intensive Care Open access 2020 148

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.